Literature DB >> 6191802

Activation of factor XII by dextran sulfate: the basis for an assay of factor XII.

D L Tankersley, B M Alving, J S Finlayson.   

Abstract

A system was developed for studying the activation of factor XII (Hageman factor) in the presence of dextran sulfate (DS). Salient features of the system included low ionic strength (0.08), low concentration of factor XII (approximately 1/10,000 that in normal plasma), and an excess of exogenous prekallikrein (PK). In this system, factor XII was rapidly converted to the 80,000 molecular weight (mol wt) form of factor XIIa (alpha-factor-XIIa). Once formed, the factor XIIa converted PK to kallikrein at a rate that was proportional to the amount of factor XII originally present in the incubation mixture. This system was used to construct a simple sensitive assay for factor XII in plasma and other biologic samples. The kallikrein produced was measured spectrophotometrically with the chromogenic substrate (H-D-Pro-Phe-Arg-p-nitroanilide (S-2302). This assay was shown to be independent of the high molecular weight kininogen and the PK content of the sample being analyzed. The measurements obtained were consistent with fundamental enzymologic principles and, if desired, could be processed with a simple calculator program to achieve linear standard curves. When applied to the quantitation of factor XII in plasma, the assay yielded values in close agreement with those determined by coagulant assay or by radial immunodiffusion.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6191802

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  4 in total

Review 1.  FXII.

Authors:  G Fuhrer; M J Gallimore; W Heller; H E Hoffmeister
Journal:  Blut       Date:  1990-11

2.  Determination of C1s-C1 inhibitor complexes in plasma by means of an enzyme linked immunosorbent assay.

Authors:  T Nilsson; O Bäck
Journal:  Clin Exp Immunol       Date:  1985-04       Impact factor: 4.330

3.  Regulation of Complement and Contact System Activation via C1 Inhibitor Potentiation and Factor XIIa Activity Modulation by Sulfated Glycans - Structure-Activity Relationships.

Authors:  Ann-Kathrin Schoenfeld; Eric Lahrsen; Susanne Alban
Journal:  PLoS One       Date:  2016-10-26       Impact factor: 3.240

4.  Factor XII as a Risk Marker for Hemorrhagic Stroke: A Prospective Cohort Study.

Authors:  Kristina Johansson; Jan-Håkan Jansson; Lars Johansson; Ingemar Bylesjö; Torbjörn K Nilsson; Mats Eliasson; Stefan Söderberg; Marcus Lind
Journal:  Cerebrovasc Dis Extra       Date:  2017-04-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.